Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients

American Journal of Transplantation

Volumn 3, Issue 9, 2003, Pages 1121-1127

  Simon, Tania ^a   Opelz, Gerhard ^a   Wiesel, Manfred ^a   Ott, Ralf C ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Granzyme B; Perforin; Renal transplantation; Serial gene expression; TaqMan real time PCR

Indexed keywords

CYCLOSPORIN; GRANZYME B; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PERFORIN; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; VALIDATION PROCESS;

BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRANZYMES; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PORE FORMING CYTOTOXIC PROTEINS; REFERENCE VALUES; REOPERATION; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES; TIME FACTORS;

EID: 0042362188     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00187.x     Document Type: Article

References (22)

1. Matas AJ. Acute rejection is a major risk factor for chronic rejection. Transplant Proc 1998; 30: 1766-1768
2. Cecka JM. The UNOS Scientific Renal Transplant Registry. Clin Transplant 1999; 13: 1-21.
3. Rush DN, Karpinski ME, Nickerson P, Dancea S, Birk P, Jeffery JR. Does subclinical rejection contribute to chronic rejection in renal transplant patients? Clin Transplant 1999; 13: 441-446.
4. Rush DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J. Protocol biopsies in renal transplantation: research tool or clinically useful? Curr Opin Nephrol Hypertens 1998; 7: 691-694.
5. Perella RR, Duerinckx AJ, Tessler FN et al. Evaluation of renal transplant dysfunction by duplex Doppler sonography: a prospective study and review of the literature. Am J Kidney Dis 1990; 15: 544-550.
6. Wiecek A, Nowicki M, Kokot F, Ritz E. Acute failure of the transplanted kidney - pathophysiology, diagnosis and prevention. Ann Transplant 1996; 1: 5-9.
7. Curtis JJ, Julian BA, Sanders CE, Herrera GA, Gaston RS. Dilemmas in renal transplantation: when the clinical course and histological findings differ. Am J Kidney Dis 1996; 27: 435-440.
8. Simon TL, Opelz G, Weimer R et al. The effect of ATG on cytokine and cytotoxic T-lymphocyte gene expression in renal allograft recipients during the early post-transplant period. Clin Transplant 2003; 17: 217-224.
9. O'Connell PJ, Pacheco-Silva A, Nickerson PW et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093-1104.
10. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954.
11. Steinmuller D. Which T cells mediate allograft rejection. Transplantation 1985; 40: 229-233.
12. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151.
13. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562-566.
14. Sabek O, Dorak MT, Kotb M, Gaber AO, Gaber L. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002; 74: 701-707.
15. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 1999; 259: 523-526.
16. Livak K. Relative Quantitation of Gene Expression: ABI PRISM 7700 Sequence Detection System: User Bulletin #2. Foster City, CA: Applied Biosystems; 1997.
17. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59: 511-514.
18. Rush DN, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129-2134.
19. Lipman ML, Shen Y, Jeffery JR et al. Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection. Transplantation 1998; 66: 1673-1681.
20. Cosimi AB, Colvin RB, Burton RC et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 1981; 305: 308-314.
21. Morton AL, Bell EB, Bolton EM et al. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078-2084.
22. Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 2001; 59: 334-341.